General ENT News

ENT

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hong RS et al. - Particular vigilance must be given to the potential for malignant invasion of the peripheral nervous system in the context of new-onset sensorineural hearing loss after chemotherapy. Such a neurologic deficit should not be assumed to be chemotherapy induced even if the hearing loss is bilaterally symmetric and the only neurologic abnormality.

Related Articles

Expression of Fractalkine Receptor CX3CR1 on Cochlear Macrophages Influences Survival of Hair Cells Following Ototoxic Injury
Journal of the Association for Research in Otolaryngology, 11/25/09    Relevance Score: 85%%

Health-related quality of life in long-term survivors of testicular cancer
Journal of Clinical Oncology, 11/02/09    Relevance Score: 77%%

Today in Clinical Pharmacology...keeping you current

Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients
Acta Oto-Laryngologica , 12/01/09

Topical use of MMC in the upper aerodigestive tract: a review on the side effects
European Archives of Oto-Rhino-Laryngology, 12/01/09

Impact of chlorhexidine mouth rinse use on postextraction infection via nitric oxide pathway
Inflammation Research, 12/01/09

Today in Otology/Neurotology...keeping you current

Phase-shift treatment for tinnitus of cochlear origin
European Archives of Oto-Rhino-Laryngology, 12/01/09

Ear-pick injury as a traumatic ossicular damage in Japan
European Archives of Oto-Rhino-Laryngology, 12/01/09

Implementation of perceptual channels in children implanted with a HiRes 90K device
Acta Oto-Laryngologica , 12/01/09